Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Survanta in Neonatal RDS
NCT02294630Phase 2Completed
- Start
- Dec 2014
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of aerosolized beractant in respiratory distress syndrome (RDS). Started Dec 2014; status: completed.
02
Drugs
aerosolized beractant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT02294630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294630.